Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines

Pediatric Nephrology

Volumn 21, Issue 2, 2006, Pages 151-159

  Klaus, G ^m   Watson, A ⁱ   Edefonti, A ^a   Fischbach, M ^b   Ronnholm K ^c   Schaefer, F ^d   Simkova, E ^e   Stefanidis, C J ^f   Strazdins, V ^g   Vande Walle, J ^h   Schroder C ^j   Zurowska, A ^k   Ekim, M ^l  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^f P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^g CHILDREN'S CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^h GHENT UNIVERSITY   (Belgium)

ⁱ NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k UNIVERSITY OF GDA SK   (Poland)

^l ANKARA UNIVERSITY   (Turkey)

^m PHILIPPS UNIVERSITY MARBURG   (Germany)

more..

Author keywords

Calcium phosphate product; Chronic renal failure; Parathyroidectomy; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE; ALUMINUM PHOSPHATE; BICARBONATE; CALCIFEDIOL; CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CALCIUM ION; CALCIUM PHOSPHATE; CITRATE CALCIUM; CITRATE SODIUM; DOXERCALCIFEROL; GROWTH HORMONE; LANTHANUM CARBONATE; MAGNESIUM CARBONATE; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; VITAMIN D; VITAMIN D DERIVATIVE;

ARTICLE; AUTOTRANSPLANTATION; BLOOD VESSEL CALCIFICATION; BONE BIOPSY; BONE GROWTH; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CARTILAGE; CHEMICAL ANALYSIS; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL STUDY; CLINICAL TRIAL; DRUG ABSORPTION; ENDOCRINE DISEASE; EUROPEAN UNION; GROWTH RETARDATION; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; METABOLIC ACIDOSIS; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; RENAL OSTEODYSTROPHY; RENAL REPLACEMENT THERAPY; VITAMIN D DEFICIENCY;

ALGORITHMS; CHILD; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL OSTEODYSTROPHY;

EID: 30944444013     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2082-7     Document Type: Article

References (85)

1. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 342:1478-1483
2. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105 10.1161/01.CIR.0000020222.63035.C0
3. Watson AR, Gartland C (2001) European Paediatric Peritoneal Dialysis Working Group Guidelines by an Ad Hoc European Committee for Elective Chronic Peritoneal Dialysis in Pediatric Patients. Perit Dial Int 21:240-244 11475338
4. Schröder CH, European Paediatric Peritoneal Dialysis Working Group (2001) The choice of dialysis solutions in pediatric chronic peritoneal dialysis: Guidelines by an ad hoc European committee. Perit Dial Int 21:568-574 11783765
5. Fischbach M, Stefanidis CJ, Watson AR, European Paediatric Peritoneal Dialysis Working Group (2002) Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription. Nephrol Dial Transplant 17:380-385 10.1093/ndt/17.3.380
6. Schröder CH, Watson AR on behalf of the European Paediatric Peritoneal Working Group (2001) The choice of dialysis solutions in chronic peritoneal dialysis: Guidelines by an ad hoc European committee. Perit Dial Int 21:568-574 11783765
7. Blind E, Schmidt-Gayk H, Armbruster FP, Stadler A (1987) Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clin Chem 33:1376-1381 3608156
8. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614 11315988
9. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H (2003) Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18:759-768 10.1093/ndt/gfg144
10. Waller S, Reynolds A, Ridout D, Cantor T, Gao P, Rees L (2003) Parathyroid hormone and its fragments in children with chronic renal failure Pediatr Nephrol 18:1242-1248
11. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Juppner H (2003) Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63:1801-1808 10.1046/j.1523-1755.2003.00915.x
12. Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L Bone Turnover Work Group (2004) Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy Am J Kidney Dis. 43:558-565
13. Lefebvre A, de Vernejoul MC, Gueris J, Goldfarb B, Graulet AM, Morieux C (1989) Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 36:1112-1118 2557481
14. Carbajo E, Lopez JM, Santos F, Ordonez FA, Nino P, Rodriguez J (2001) Histologic and dynamic change induced by chronic metabolic acidosis in the rat growth plate. J Am Soc Nephrol 12:1228-1234 11373346
15. Kalhoff H, Manz F (2001) Nutrition, acid-base status and growth in early childhood. Eur J Nutr 40:221-230 10.1007/s394-001-8349-y
16. Kovacic V, Roguljic L, Kovacic V (2003) Metabolic acidosis of chronically hemodialyzed patients. Am J Nephrol 23:158-164 10.1159/ 000070205
17. Feriani M, Carobi C, La Greca G, Buoncristiani U, Passlick-Deetjen J (1997) Clinical experience with a 39 mmol/l bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 17:17-21 9068017
18. Coburn JW, Mischel MG, Goodman WG, Salusky IB (1991) Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis 17:708-711 2042654
19. K/DOQI (2004) Clinical practice guidelines for bone metabolism and disease in chronic kidney disease Epub: www.kidney.org/professionals/ kdoqi/guidelines_bone/index.htm
20. Norman LJ, Coleman JE, Macdonald I, Tomsett A, Watson AR (2000) Nutrition and growth in relation to severity of renal disease in children. Pediatr Nephrol 14:833-836 10.1007/s004670000318
21. Slatopolsky E, Bricker NS (1973) The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 4:141-145 4355426
22. Kilav R, Silver J, Naveh-Many T (1995) Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 96:327-333 7615802
23. Naveh-Many T, Rahamimov R, Livni N, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96:1786-1793 7560070
24. Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M (1996) Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11:970-976 8797118
25. Portale AA, Booth BE, Halloran BP, Morris RC Jr (1984) Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580-1589 6547151
26. Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T (1999) Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int [Suppl] 73:S2-7
27. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K (1995) Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus. Nephron 70:242-248 7566311
28. Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936 2266678
29. Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617 9531176
30. Huting J (1994) Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis. Chest 105:383-388 8306733
31. Ribeiro S, Ramos A, Brandao A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remedio F, Ribeiro F (1998) Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 13:2037-2040 10.1093/ndt/13.8.2037
32. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647 10.1046/j.1523-1755.2002.00170.x
33. Shioi A, Taniwaki H, Jono S, Okuno Y, Koyama H, Mori K, Nishizawa Y (2001) Monckeberg's medial sclerosis and inorganic phosphate in uremia. Am J Kidney Dis 38 [Suppl 1]:S47-49
34. Amann K, Tornig J, Kugel B, Gross ML, Tyralla K, El-Shakmak A, Szabo A, Ritz E (2003) Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63:1296-1301 10.1046/j.1523-1755.2003.00864.x
35. Coleman JE, Edefonti A, Watson AR on behalf of the European Pediatric Peritoneal Working Group (2001) Guidelines by an ad hoc European committee on the assessment of growth and nutritional status in children on chronic peritoneal dialysis. Perit Dial Int 21:323 (www.ispd.org.guidelines)
36. Schaefer F, Langenbeck D, Heckert KH, Scharer K, Mehls O (1992) Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv Perit Dial 8:410-415 1361835
37. Fischbach M, Boudailliez B, Foulard M (1997) Phosphate end dialysis value: A misleading parameter of hemodialysis efficiency. Pediatr Nephrol 11:193-195 10.1007/s004670050258
38. Maasrani M, Jaffrin MY, Fischbach M, Boudailliez B (1995) Urea creatinine and phosphate kinetic modelling during dialysis: Application to pediatric hemodialysis. Int J Artif Organs 18:122-129 7499014
39. Bell L, Espinosa P (2003) Intensive in center hemodialysis for children: a case for longer dialysis duration. Hemodial Int 7:290-295 10.1046/ j.1492-7535.2003.00052.x
40. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA (2003) Change from three times a week on line hemodiafiltration to short daily on line hemodiafiltration. Kidney Int 64:305-313 10.1046/ j.1523-1755.2003.00043.x
41. Traeger S, Galland R, Arkouche W, Delawari E, Fouque D (2001) Short daily hemodialysis: A 4-year experience. Dialysis Transplant 30:76-86
42. Fischbach M, Hamel G, Simeoni U, Geisert J (1992) Phosphate dialytic removal: Enhancement of phosphate cellular clearance by biofiltration (with acetate free buffer dialysate). Nephron 62:155-160 1436307
43. Fischbach M, Terzic J, Cousandier E, Hamel G, Geisert J (1998) Glucose charged dialysate for children on hemodialysis: Acute dialytic changes. Pediatr Nephrol 12:60-62 10.1007/s004670050404
44. Fischbach M, Terzic J, Laugel V, Dheu C, Menouer S, Helms P, Livolsi A (2004) Daily on line hemodiafiltration: A pilot experience in children. Nephrol Dial Transpl (submitted)
45. Schiller LR, Santa Ana CA, Sheikh MS, Emmett M, Fordtran JS (1989) Effect of the time of administration of calcium acetate on phosphorus binding. New Engl J Med 27:1110-1113
46. Wallot M, Bonzel KE, Winter A, Georger B, Lettgen B, Bald M (1996) Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients. Pediatr Nephrol 10:625-630 10.1007/s004670050175
47. Pflanz S, Henderson IS, McElduff N, Jones MC (1994) Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis. Nephrol Dial Transplant 9:1121-1124
48. Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482 2333868
49. D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME (2003) A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int [Suppl] 85:S73-78
50. Fernandez-Gavarron F, Huque T, Rabinowitz JL, Brand JG (1988) Incorporation of 140-lanthanum into bones, teeth and hydroxyapatite. Bone Miner 3:283-291
51. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E (1991) Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 6:162-169 1866044
52. Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E (1988) Extra-renal production of calcitriol in chronic renal failure. Kidney Int 34:368-375 3172645
53. Van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346:207-210 10.1016/ S0140-6736(95)91266-5
54. Birge SJ, Haddad JG (1975) 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56:1100-1107 1184737
55. Ritz E, Küster S, Schmidt-Gayk H, Stein G, Scholz C, Kraatz G, Heidland A (1995) Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant 10:2228-2234 8808216
56. Waller S, Ledermann S, Trompeter R, van't Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18:1236-1241 10.1007/s00467-003-1284-0
57. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258 8127016
58. Piscitelli J, Cabansag MR, Silverstein DM (1999) Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients. J Pediatr Endocrinol Metab 12:879-886 10614547
59. Klaus G, Mehls O, Hinderer J, Ritz E (1991) Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism? Lancet 337:800-801 10.1016/0140-6736(91)91429-X
60. Ballanti P, Wedard BM, Bonucci E (1996) Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients - retrospective analysis of 1,429 iliac crest biopsies. Nephrol Dial Transplant 11:663-667 8671855
61. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205-211 10.1046/ j.1523-1755.1998.00724.x
62. Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O (1996) Low calcium (1.25 mmol/l) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover. Adv Perit Dial 12:250-256 8865914
63. Ardissino G, Schmitt CP, Testa S, Claris-Appiani A, Mehls O (2000) Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure. Pediatr Nephrol 14:664-668 10.1007/s004670000365
64. Tsuruoka S, Wakaumi M, Sugimoto K, Saito T, Fujimura A (2003) Chronotherapy of high-dose active vitamin D3 in haemodialysis patients with secondary hyperparathyroidsm: A repeated dosing study.Br J Clin Pharmacol 55:531-537 10.1046/j.1365-2125.2003.01809.x
65. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166 7861712
66. Klaus G, König B, Hügel U, Ritz E, Mehls O (1993) Intermittent and continuous exposure to 1,25(OH)2D3 have different effects on growth plate chondrocytes in vitro. Kidney Int 44:708-715 8258948
67. Mehls O, Knoller N, Oh J, Wesch H, Wunsche B, Schmitt CP (2000) Daily but not pulse calcitriol therapy improves growth in experimental uremia. Pediatr Nephrol 14:658-663 10.1007/s004670000346
68. Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18:440-444 12687466
69. Ardissino G, Schmitt CP, Bianchi ML, Dacco V, Claris-Appiani A, Mehls O (2000) No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure. Kidney Int 58:981-988 10.1046/j.1523-1755.2000.00255.x
70. Herrmann P, Ritz E, Schmidt-Gayk H, Schafer I, Geyer J, Nonnast-Daniel B, Koch KM, Weber U, Horl W, Haas-Worle A (1994) Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: A randomized prospective trial. Nephron 67:48-53 8052367
71. Sprague SM, Llach F, Amdahl M, Taccetta C, Batlle D (2003) Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 63:1483-1490 10.1046/j.1523-1755.2003.00878.x
72. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516-1525 10.1056/NEJMoa031633
73. Tönshoff B, Blum WF, Mehls O (1997) Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int [Suppl] 58:S106-113
74. Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343:923-930 10.1056/ NEJM200009283431304
75. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA (2004) Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 180:247-255 10.1677/ joe.0.1800247
76. Olney RC (2003) Regulation of bone mass by growth hormone. Med Pediatr Oncol 41:228-234 10.1002/mpo.10342
77. Loder RT, Hensinger RN (1997) Slipped capital femoral epiphysis associated with renal failure osteodystrophy. J Pediatr Orthop 17:205-211 10.1097/00004694-199703000-00013
78. Fine RN, Ho M, Tejani A, Blethen S (2003) Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J Pediatr 142:539-545 10.1067/mpd.2003.189
79. Berard E, Crosnier H, Six-Beneton A, Chevallier T, Cochat P, Broyer M (1998) Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr Nephrol 12:304-310 10.1007/s004670050459
80. Picca S, Cappa M, Martinez C, Moges SI, Osborn J, Perfumo F, Ardissino G, Bonaudo R, Montini G, Rizzoni G (2004) Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone. Pediatr Nephrol 19:71-76 10.1007/s00467-003-1283-1
81. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E, Kurokawa K (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68:221-228 7830860
82. Okuno S, Ishimura E, Kitatani K, Chou H, Nagasue K, Maekawa K, Izumotani T, Yamakawa T, Imanishi Y, Shoji T, Inaba M, Nishizawa Y (2003) Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 18:2613-2621 10.1093/ndt/gfg451
83. Kakuta T, Fukagawa M, Fujisaki T, Hida M, Suzuki H, Sakai H, Kurokawa K, Saito A (1999) Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 33:1091-1099 10352197
84. Schömig M, Ritz E (2000) Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy. Nephrol Dial Transplant 15 [Suppl 5]:25-29
85. Quarles LD, Sherrard DJ, Adler S, Rosansky SJ, McCary LC, Liu W, Turner SA, Bushinsky DA (2003) The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 14:575-583 10.1097/01.ASN.0000050224.03126.AD